Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial — Oct 16th, 2024

Microbot Medical, Inc. MBOT has successfully completed patient enrollment and follow-up in its ACCESS-PVI human clinical trial, which evaluates the performance and safety of the LIBERTY Endovascular Robotic Surgical System in Peripheral Vascular Interventions. The company is now set to fi...

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device — Oct 16th, 2024

AtriCure, Inc. (ATRC) has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe. cryoNB therapy, using AtriCure’s cryoICE technology...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device — Oct 16th, 2024

AtriCure, Inc. (ATRC) has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe. cryoNB therapy, using AtriCure’s cryoICE technology...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial — Oct 16th, 2024

Microbot Medical, Inc. MBOT has successfully completed patient enrollment and follow-up in its ACCESS-PVI human clinical trial, which evaluates the performance and safety of the LIBERTY Endovascular Robotic Surgical System in Peripheral Vascular Interventions. The company is now set to fi...

Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch — Oct 17th, 2024

Aurora Cannabis Inc. ACB and MedReleaf Australia, a subsidiary of Aurora Cannabis, have announced the launch of an enhanced range of premium medical cannabis oils in Australia. These new products, including varying cannabinoid ratios such as Tetrahydrocannabinol (THC) and Cannabidiol (CBD...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device — Oct 16th, 2024

AtriCure, Inc. (ATRC) has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe. cryoNB therapy, using AtriCure’s cryoICE technology...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval — Oct 21st, 2024

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation (PFA) for treating paroxysmal atrial fibrillation (AF). The technologies streamline workflows ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call — Oct 21st, 2024

FRISCO, Texas, October 21, 2024--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2024, on Monday, November 4, 2024, after the market close. Addus HomeCare ...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...

Myriad Genetics Shares Fall Despite Partnership With jscreen — Oct 18th, 2024

Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This collaboration merges Myriad’s advanced hereditary cancer and reproductive genetic products, MyRis...